ask="6.97"
ask_size="100"
average_daily_volume="35557"
bid="5.59"
bid_size="100"
book_value="1.81"
change="-0.01"
change_from_200_day_moving_average="-0.84"
change_from_50_day_moving_average="0.10"
change_from_52_week_high="-4.17"
change_From_52_week_low="0.74"
change_in_percent="-0.16%"
close="6.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.86"
ebitda="-9.95M"
eps_estimate_current_year="-0.62"
eps_estimate_next_quarter="-0.13"
eps_estimate_next_year="-1.01"
ex_dividend_date="N/A"
float_shares="8657000"
high="6.38"
high_52_weeks="10.51"
last_trade_date="1/13/2017"
last_trade_price="6.34"
last_trade_size="100"
last_trade_time="3:49pm"
low="6.25"
low_52_weeks="5.60"
market_capitalization="84.21M"
moving_average_200_day="7.18"
moving_average_50_day="6.24"
name="Oramed Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="18.00"
open="6.31"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-11.74%"
percent_change_from_50_day_moving_average="+1.62%"
percent_change_from_52_week_high="-39.68%"
percent_change_from_52_week_low="+13.21%"
previous_close="6.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.51"
price_per_sales="67.42"
revenue="1.25M"
shares_outstanding="13283000"
short_ratio="6.22"
stock_exchange="NCM"
symbol="ORMP"
volume="7032"
weeks_range_52="5.60 - 10.51"
